LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Mutation detection in saliva from oral cancer patients.

    Ahmed, Ahmed A / Sborchia, Mateja / Bye, Hannah / Roman-Escorza, Maria / Amar, Ariella / Henley-Smith, Rhonda / Odell, Edward / McGurk, Mark / Simpson, Michael / Ng, Tony / Sawyer, Elinor J / Mathew, Christopher G

    Oral oncology

    2024  Volume 151, Page(s) 106717

    Abstract: Objectives: The incidence of head and neck squamous cell carcinoma (HNSCC) continues to increase and although advances have been made in treatment, it still has a poor overall survival with local relapse being common. Conventional imaging methods are ... ...

    Abstract Objectives: The incidence of head and neck squamous cell carcinoma (HNSCC) continues to increase and although advances have been made in treatment, it still has a poor overall survival with local relapse being common. Conventional imaging methods are not efficient at detecting recurrence at an early stage when still potentially curable. The aim of this study was to test the feasibility of using saliva to detect the presence of oral squamous cell carcinoma (OSCC) and to provide additional evidence for the potential of this approach.
    Materials and methods: Fresh tumor, whole blood and saliva were collected from patients with OSCC before treatment. Whole exome sequencing (WES) or gene panel sequencing of tumor DNA was performed to identify somatic mutations in tumors and to select genes for performing gene panel sequencing on saliva samples.
    Results: The most commonly mutated genes identified in primary tumors by DNA sequencing were TP53 and FAT1. Gene panel sequencing of paired saliva samples detected tumor derived mutations in 9 of 11 (82%) patients. The mean variant allele frequency for the mutations detected in saliva was 0.025 (range 0.004 - 0.061).
    Conclusion: Somatic tumor mutations can be detected in saliva with high frequency in OSCC irrespective of site or stage of disease using a limited panel of genes. This work provides additional evidence for the suitability of using saliva as liquid biopsy in OSCC and has the potential to improve early detection of recurrence in OSCC. Trials are currently underway comparing this approach to standard imaging techniques.
    MeSH term(s) Humans ; Mouth Neoplasms/diagnosis ; Mouth Neoplasms/genetics ; Mouth Neoplasms/pathology ; Carcinoma, Squamous Cell/diagnosis ; Carcinoma, Squamous Cell/genetics ; Saliva ; Neoplasm Recurrence, Local ; Squamous Cell Carcinoma of Head and Neck ; Mutation ; Head and Neck Neoplasms ; Biomarkers, Tumor/genetics
    Chemical Substances Biomarkers, Tumor
    Language English
    Publishing date 2024-02-26
    Publishing country England
    Document type Journal Article
    ZDB-ID 1120465-5
    ISSN 1879-0593 ; 0964-1955 ; 1368-8375
    ISSN (online) 1879-0593
    ISSN 0964-1955 ; 1368-8375
    DOI 10.1016/j.oraloncology.2024.106717
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The Impact of p53 on Aristolochic Acid I-Induced Gene Expression In Vivo.

    Sborchia, Mateja / Keun, Hector C / Phillips, David H / Arlt, Volker M

    International journal of molecular sciences

    2019  Volume 20, Issue 24

    Abstract: Exposure to aristolochic acid (AA) is linked to kidney disease and urothelial cancer in humans. The major carcinogenic component of the AA plant extract is aristolochic acid I (AAI). The tumour suppressor p53 is frequently mutated in AA-induced tumours. ... ...

    Abstract Exposure to aristolochic acid (AA) is linked to kidney disease and urothelial cancer in humans. The major carcinogenic component of the AA plant extract is aristolochic acid I (AAI). The tumour suppressor p53 is frequently mutated in AA-induced tumours. We previously showed that p53 protects from AAI-induced renal proximal tubular injury, but the underlying mechanism(s) involved remain to be further explored. In the present study, we investigated the impact of p53 on AAI-induced gene expression by treating
    MeSH term(s) Animals ; Aristolochic Acids/pharmacology ; Genotype ; Kidney/drug effects ; Kidney/metabolism ; Male ; Mice ; Proteomics/methods ; Signal Transduction/drug effects ; Signal Transduction/genetics ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism
    Chemical Substances Aristolochic Acids ; Tumor Suppressor Protein p53 ; aristolochic acid I (94218WFP5T)
    Language English
    Publishing date 2019-12-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms20246155
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro.

    Sborchia, Mateja / De Prez, Eric G / Antoine, Marie-Hélène / Bienfait, Lucie / Indra, Radek / Valbuena, Gabriel / Phillips, David H / Nortier, Joëlle L / Stiborová, Marie / Keun, Hector C / Arlt, Volker M

    Archives of toxicology

    2019  Volume 93, Issue 11, Page(s) 3345–3366

    Abstract: Exposure to aristolochic acid (AA) is associated with human nephropathy and urothelial cancer. The tumour suppressor TP53 is a critical gene in carcinogenesis and frequently mutated in AA-induced urothelial tumours. We investigated the impact of p53 on ... ...

    Abstract Exposure to aristolochic acid (AA) is associated with human nephropathy and urothelial cancer. The tumour suppressor TP53 is a critical gene in carcinogenesis and frequently mutated in AA-induced urothelial tumours. We investigated the impact of p53 on AAI-induced nephrotoxicity and DNA damage in vivo by treating Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice with 3.5 mg/kg body weight (bw) AAI daily for 2 or 6 days. Renal histopathology showed a gradient of intensity in proximal tubular injury from Trp53(+/+) to Trp53(-/-) mice, especially after 6 days. The observed renal injury was supported by nuclear magnetic resonance (NMR)-based metabonomic measurements, where a consistent Trp53 genotype-dependent trend was observed for urinary metabolites that indicate aminoaciduria (i.e. alanine), lactic aciduria (i.e. lactate) and glycosuria (i.e. glucose). However, Trp53 genotype had no impact on AAI-DNA adduct levels, as measured by
    MeSH term(s) Animals ; Aristolochic Acids/metabolism ; Aristolochic Acids/toxicity ; Cells, Cultured ; Cytochrome P-450 CYP1A1/genetics ; DNA Damage ; Fibroblasts/drug effects ; Fibroblasts/metabolism ; Fibroblasts/pathology ; Gene Expression/drug effects ; Kidney Function Tests ; Kidney Tubules, Proximal/drug effects ; Kidney Tubules, Proximal/metabolism ; Kidney Tubules, Proximal/pathology ; Male ; Mice, Inbred C57BL ; Mice, Knockout ; Mutagens/metabolism ; Mutagens/toxicity ; NAD(P)H Dehydrogenase (Quinone)/genetics ; Tumor Suppressor Protein p53/genetics
    Chemical Substances Aristolochic Acids ; Mutagens ; Trp53 protein, mouse ; Tumor Suppressor Protein p53 ; aristolochic acid I (94218WFP5T) ; Cyp1a1 protein, mouse (EC 1.14.14.1) ; Cytochrome P-450 CYP1A1 (EC 1.14.14.1) ; NAD(P)H Dehydrogenase (Quinone) (EC 1.6.5.2) ; Nqo1 protein, mouse (EC 1.6.5.2)
    Language English
    Publishing date 2019-10-10
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 124992-7
    ISSN 1432-0738 ; 0340-5761
    ISSN (online) 1432-0738
    ISSN 0340-5761
    DOI 10.1007/s00204-019-02578-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top